NVIC Articles

side-panel

Disease-Vaccine-Landing-Page/side-panel

Latest articles

Browse Articles

Placeholder image
Page

High doses of vitamin C given intravenously (IV) have been used to treat COVID-19. Three clinical trials and several smaller studies reported successful outcomes among patients who received IV vitamin...

Placeholder image
Page

In early August 2020, Mayo Clinic researchers reported that blood plasma donated from individuals who had recovered from COVID-19, was helpful despite a lack a formal data to support its...

Placeholder image
Page

Because the SARS-CoV-2 virus was new, there were no FDA approved drugs specific to this new virus. This resulted in some health care professionals using their clinical experience to treat...

Placeholder image
Page

Emergency Use Authorization (EUA) is a status given to experimental and licensed products by the FDA during a public health emergency, as defined under federal law.   Monoclonal AntibodiesIn 2020, the...

Placeholder image
Page

According to the CDC, most people who become ill with COVID-19 will not require any specific treatment, with over-the-counter fever and pain reducers to relieve aches and pains associated with...

Placeholder image
Page

A review published in May 2020  stated that while there were no published nutrition studies specific to COVID-19 and SARS-CoV-2, there was evidence from acute respiratory distress syndrome in other...

Placeholder image
Page

Individuals who are deficient in vitamin D have been found to be at an increased risk of severe COVID-19 disease.    In addition to strengthening teeth and bones, vitamin D...

Placeholder image
Page

While the CDC continues to promote the use of masks as a method to reduce the risk of viral transmission, and report that consistently wearing a well-fitted mask is better...

Placeholder image
Page

Increased HIV infection riskCOVID-19 vaccines that use a recombinant adenovirus type-5 (Ad5) vector may increase the risk of HIV infection in males. In 2007, researchers testing an experimental HIV vaccine...

Placeholder image
Page

Individuals, especially women between the ages of 18 and 49, who receive the Janssen/Johnson & Johnson COVID-19 vaccine may be at risk for a serious and potentially fatal blood clot...

Topics
Select disease / vaccine